Bright Jonathan, Aylott Mike, Bate Simon, Geys Helena, Jarvis Philip, Saul Jim, Vonk Richardus
Discovery Statistics, AstraZeneca R&D, Macclesfield, Cheshire, UK.
Pharm Stat. 2011 Nov-Dec;10(6):485-93. doi: 10.1002/pst.530. Epub 2011 Nov 30.
In 2010, the Statisticians in the Pharmaceutical Industry (PSI) Toxicology Special Interest Group met to discuss the design and analysis of the Comet assay. The Comet assay is one potential component of the package of safety studies required by regulatory bodies. As these studies usually involve a three-way nested experimental design and as the distribution of the measured response is usually either lognormal or lognormal plus a point mass at zero, the analysis is not straightforward. This has led to many different types of analysis being proposed in the literature, with several different methods applied within the pharmaceutical industry itself. This article summarises the PSI Toxicology Group's discussions and recommendations around these issues.
2010年,制药行业统计学家(PSI)毒理学特别兴趣小组召开会议,讨论彗星试验的设计与分析。彗星试验是监管机构要求的一揽子安全性研究中一个潜在组成部分。由于这些研究通常涉及三向嵌套实验设计,且所测反应的分布通常要么呈对数正态分布,要么是对数正态分布加上一个零处的点质量分布,所以分析并不简单直接。这导致文献中提出了许多不同类型的分析方法,制药行业内部也应用了几种不同的方法。本文总结了PSI毒理学小组围绕这些问题展开的讨论及建议。